Acetylcholinesterase Inhibitors, AMD, and Alzheimer Disease-Reply
JAMA Ophthalmol
.
2024 Jul 1;142(7):684-685.
doi: 10.1001/jamaophthalmol.2024.1204.
Authors
Joseph Magagnoli
1
2
,
S Scott Sutton
1
2
,
Jayakrishna Ambati
3
4
5
6
Affiliations
1
Dorn Research Institute, Columbia VA Health Care System, Columbia, South Carolina.
2
Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia.
3
Center for Advanced Vision Science, University of Virginia School of Medicine, Charlottesville.
4
Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville.
5
Department of Pathology, University of Virginia School of Medicine, Charlottesville.
6
Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville.
PMID:
38722622
DOI:
10.1001/jamaophthalmol.2024.1204
No abstract available
Publication types
Letter
MeSH terms
Alzheimer Disease* / drug therapy
Cholinesterase Inhibitors* / therapeutic use
Humans
Macular Degeneration / drug therapy
Substances
Cholinesterase Inhibitors